Advertisement
Alkermes plc

Alkermes plc (ALKS) Stock Overview

Explore Alkermes plc’s financial performance, market position, analyst ratings, and future outlook.

ALKSNASDAQ
HealthcareBiotechnology
$51.98
$0.38(0.74%)
U.S. Market opens in 16h 12m
Advertisement

Alkermes plc (ALKS)

Meyka AI Score

Z

Key Financials

Market Cap8.7B
P/E Ratio55.07
EPS (TTM)$0.95
ROE0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$50.83
3 Months$46.00
1 Year Target$34.62

ALKS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Alkermes plc (ALKS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 60.79, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $34.62.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 55.07 and a market capitalization of 8.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.74%
5-Day Change
-2.59%
1-Month Change
17.18%
3-Month Change
56.47%
6-Month Change
66.50%
Year-to-Date (YTD) Change
85.78%
1-Year Change
80.17%
3-Year Change
69.98%
5-Year Change
119.79%
All-Time (Max) Change
845.09%

Contact Information

353 1 772 8000
Connaught House, Dublin, DU, D04 C5Y6

Company Facts

20,950 Employees
IPO DateJul 16, 1991
CountryIE
Actively Trading

Frequently Asked Questions